Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-10-26
1997-02-11
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514221, 5142278, 5142288, 514248, 514315, 514396, 514405, 514408, A61K 3155
Patent
active
056021224
ABSTRACT:
The present invention relates to the use of certain aminoacetylmercapto derivatives in treating patients suffering from hypercholesterolemia.
REFERENCES:
patent: 3334091 (1967-07-01), Houlihan
patent: 3334095 (1967-08-01), Houluhan
patent: 4080449 (1978-03-01), Croisier et al.
patent: 4320057 (1982-03-01), Freed et al.
patent: 4391752 (1983-07-01), Crossley
patent: 4399136 (1983-08-01), Hassall et al.
patent: 4415496 (1983-11-01), Harris et al.
patent: 4487929 (1984-12-01), Hassall et al.
patent: 4512924 (1985-04-01), Attwood et al.
patent: 4584294 (1986-04-01), Ruyle
patent: 4658024 (1987-04-01), Attwood et al.
patent: 4692438 (1987-09-01), Hassall et al.
patent: 4716232 (1987-12-01), Ternansky
patent: 4734504 (1988-03-01), Holmes
patent: 4734505 (1988-03-01), Holmes
patent: 4762924 (1988-08-01), Hassall et al.
patent: 4772701 (1988-09-01), Attwood et al.
patent: 4782149 (1988-11-01), Lawton et al.
patent: 4785093 (1988-11-01), Hassall et al.
patent: 4808713 (1989-02-01), Attwood et al.
patent: 4824832 (1989-04-01), Flynn et al.
patent: 4826980 (1989-05-01), Hassall et al.
patent: 4973585 (1990-11-01), Flynn et al.
patent: 5208230 (1993-05-01), Flynn et al.
patent: 5238932 (1994-07-01), Flynn et al.
patent: 5366973 (1994-11-01), Flynn et al.
Costa F. V. et al., American Journal of Hypertension, vol. 1, No. 3 (1988) pp. 221S-223S.
Current Opin Ther. Pat., vol. 3, No. 1, (1993) pp. 162-164.
Flynn, et al., J. Am. Chem. Soc. 109, 7914 (1987).
Flynn, et al., Peptide Chemistry (1987); T. Shiba & Sakakibara (ed.), Protein Research Foundation, Osaka (1988).
Flynn, et al., Tetrahedron Letters, vol. 31 (6), 815-88 (1990).
Attwood, et al., J. Chem. Soc. Perkin Trans. I, pp. 1011-1019 (1986).
Natoff, et al., Drugs of the Future, vol. 12 (5): 475-483 (1987).
Davis, Harry R. et. al., Supplement I Circulation, vol. 86, No. 4 p. I-220(0873), (Oct. 1992).
Powell Jerry S. et al., Journal of American College of Cardiology, vol. 17, No. 6, pp. 137B-142 B (May 1991).
J. Med. Chem. (1992), 35, 823-832, Timothy D. Ocain et al.
Bioorganic and Medical Chem. Letters Vo. 1, 309, (1991).
Fournie-Zaluski, Marie-Claude et al., J. Med. Chem., (1992) vol. 35, pp. 2473-2481.
Fournie-Zaluski, Marie-Claude et al., J. Med. Chem., (1992) vol. 35, pp. 1259-1266.
French, John F., Jour. of Pharm and Exper. Therapeutics, vol. 268, No. 1, pp. 180-186. (1994).
W. H. Parsons et al. Biochemical and Biophysical Research Communications vol. 117, No. 1, (1993) (Nov. 30, 1983).
Kuglyama et al., Circulation "Abstract from the 66th Scientific Sessions" 88(4), (1993,) p. I-521.
Burkholder, et al. Bioorganic and Medical Chem. Letters, vol. 3, No. 2, pp. 231-234, (1993).
Flynn et al., J. Med. Chem. (1993,) 36 2420-2423.
Chemical Abstracts (121:9999), (1994).
Dage Richard C.
Flynn Gary A.
French John F.
Barney Charlotte L.
Merrell Pharmaceuticals Inc.
Weddington Kevin E.
LandOfFree
Method for lowering total serum cholesterol and treating hyperch does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for lowering total serum cholesterol and treating hyperch, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for lowering total serum cholesterol and treating hyperch will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342210